Reinhard Ambros

Reinhard Ambros has joined the board of directors of Synthetic Genomics. He was the global head of the Novartis Venture Fund from 2005 until 2017. Prior to that, he was head of group strategic planning at Novartis and led business development and licensing in the cardiovascular and metabolic disease area for Novartis Pharma. Ambros holds a PhD from the University of Regensburg in Germany.